Urinary myelin figures in gentamicin nephrotoxicity

Area of Science:

• Nephrology
• Toxicology
• Cell Biology

Background:

• Gentamicin nephrotoxicity is a significant clinical concern.
• Myelin figure formation in renal tubules is a known indicator of gentamicin-induced kidney damage in animal models.
• The presence and diagnostic utility of urinary myelin figures in human gentamicin nephrotoxicity remain to be fully elucidated.

Purpose of the Study:

• To investigate the occurrence of urinary myelin figures in patients undergoing gentamicin therapy.
• To determine if urinary myelin figures correlate with gentamicin-induced nephrotoxicity.
• To compare the morphology of urinary myelin figures in gentamicin nephrotoxicity with those in Fabry disease.

Main Methods:

• Electron microscopy was used to examine urinary sediments from multiple patient groups.
• Patients were categorized based on gentamicin treatment and renal function status.
• Urinary sediments were analyzed for the presence and morphology of myelin figures.

Main Results:

• Numerous urinary myelin figures were observed in all three patients with renal impairment receiving gentamicin.
• Myelin figures were absent in patients without renal impairment, regardless of gentamicin therapy.
• Occasional myelin figures were found in one patient with renal impairment but no gentamicin therapy.
• Morphological distinctions were noted between myelin figures associated with gentamicin nephrotoxicity and Fabry disease.

Conclusions:

• The presence of urinary myelin figures is associated with acute renal failure in patients treated with gentamicin.
• Urinary myelin figures may serve as a potential diagnostic biomarker for gentamicin-induced nephrotoxicity.
• Further research can explore the diagnostic value and specificity of urinary myelin figures in kidney disease.